Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Talimus LS Ointment

Prescription Icon
Prescription Required

Marketer

Ajanta Pharma Ltd

Salt Composition

Tacrolimus (0.03% w/w)

Overview Talimus LS Ointment

Atopic dermatitis (eczema) is treated with Talimus LS Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Talimus LS Ointment externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly spread the ointment until fully absorbed. Avoid overuse and do not bandage or cover treated skin. Consult your doctor if symptoms don't improve after two weeks or worsen. Common side effects may include skin redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Generally, this ointment isn't advised during pregnancy or breastfeeding unless absolutely necessary.

Uses of Talimus LS Ointment

Managing atopic dermatitis

Major Benefits of Talimus LS Ointment:

Apply this medication topically only. Administer it as directed by your physician, adhering to the prescribed dosage and treatment length. Always consult the product label for application instructions prior to use. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Talimus LS Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Talimus LS Ointment:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying, ensure the affected area is clean and dry, then gently rub in the ointment.

How Talimus LS Ointment works:

Talimus LS Ointment is an immunosuppressive topical agent. Its mechanism of action involves inhibiting the inflammatory response of specific immune cells within the skin, thus reducing skin redness, swelling, and itching associated with atopic dermatitis and improving the rash.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Talimus LS Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Use of Talimus LS Ointment while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant exposure.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Talimus LS Ointment :

Forgo Talimus LS Ointment application only if your next scheduled dose is imminent; otherwise, apply the missed dose immediately and then resume your usual dosing regimen.

Facts to Know About Talimus LS Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Medication Classification Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitors

FAQs on Talimus LS Ointment

Talimus LS Ointment is an immunomodulatory medication that primarily reduces immune system activity. It's indicated for adults with moderate to severe atopic dermatitis (eczema) unresponsive to or experiencing adverse effects from steroid treatments. Atopic dermatitis involves an overactive skin immune response, resulting in inflammation, itching, redness, and dryness. Talimus LS Ointment modifies this aberrant immune reaction, consequently alleviating skin inflammation and itching.
Topical application of Talimus LS Ointment may induce localized skin reactions including irritation, burning, and pruritus. These reactions typically range from mild to moderate in intensity and usually subside within seven days of treatment initiation. Erythema is frequently observed, accompanied by warmth, discomfort, paresthesia, and rash at the application site. Treatment also elevates the likelihood of folliculitis, herpes labialis, acne, and disseminated herpes simplex virus infections.
Talimus LS Ointment offers a safe and effective short-term topical treatment option for atopic dermatitis, exhibiting superior safety compared to other immunosuppressant medications. Its low systemic absorption following cutaneous application results in a reduced incidence of adverse effects relative to oral administration.
Talimus LS Ointment is not a controlled substance and does not present a risk of misuse. Controlled substances, by definition, have a potential for abuse, requiring authorization from both medical professionals and regulatory bodies.
Prolonged application of Talimus LS Ointment is associated with a heightened lymphoma risk, a type of lymph node tumor. Limited research indicates a correlation between the use of Talimus LS Ointment or comparable products and the development of skin cancer or lymphoma in a small number of patients. Seek medical advice if Talimus LS Ointment is needed for over six weeks, or if your eczema symptoms fail to improve or worsen during treatment.
Talimus LS Ointment lacks steroid components. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. A key benefit is its avoidance of skin thinning and other adverse effects associated with steroids.
Talimus LS Ointment
264
MRP 322
18% off